Zobrazeno 1 - 10
of 48
pro vyhledávání: '"MC Muñoz-Villanueva"'
Autor:
Jordi Muntané, María J. Rubio, Rafael Díaz, F.C. Muñoz-Casares, MC Muñoz-Villanueva, S. Rufian, Carlos J. Díaz, Alvaro Arjona, Ángela Casado
Publikováno v:
Clinical and Translational Oncology. 11:753-759
Peritoneal carcinomatosis in women frequently has an ovarian origin. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) along with radical surgery/peritonectomy could present a new therapeutic approach with curative intention. The purpo
Autor:
MC Muñoz-Villanueva, Raúl González González, Francisco J. Padillo, María D. Perea, Adolfo Cruz, Reyes Vázquez, Juan F. Ruiz-Rabelo, Jordi Muntané, Pedro Montilla, Ana Otero Romero, Isaac Túnez
Publikováno v:
Journal of Pineal Research. 43:270-275
Pancreatic cancer is a major health problem because of the aggressiveness of the disease and the lack of effective systemic therapies. Melatonin has antioxidant activity and prevents experimental genotoxicity. However, the effect of melatonin in panc
Autor:
F.C. Muñoz-Casares, Francisco Javier Medina-Fernández, María J. Rubio, Rosa Ortega-Salas, MC Muñoz-Villanueva, Sebastián Rufián-Peña, Ángela Casado-Adam, F.J. Briceño, Álvaro Arjona-Sánchez, J.M. Sánchez-Hidalgo
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 42(2)
Background Cytoreductive surgery with peritonectomy procedures and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC) represents a radical therapeutic approach to achieve complete cytoreduction in ovarian peritoneal carcinomatosis. The aim of th
Autor:
Juan D. Cañete, Eduardo Collantes-Estevez, Juan Carlos Torre-Alonso, Raimon Sanmartí, Pedro Zarco, Carlos M. González, MC Muñoz-Villanueva, Jordi Gratacós
Publikováno v:
Rheumatology. 44:1555-1558
OBJECTIVE To evaluate the therapeutic effectiveness of reducing the infliximab dose interval to 6 weeks in spondyloarthropathy patients not responding to 5 mg/kg every 8 weeks. METHODS After 30 weeks of infliximab therapy, 25 patients were classified
Autor:
Olga DelaRosa, Luis F. Rioja, Raquel Tarazona, José Peña, Javier G. Casado, MC Muñoz-Villanueva, Rocío Soto, Rafael Solana, Esther Peralbo
Publikováno v:
Cancer Immunology, Immunotherapy. 54:1162-1171
CD8+ T cells can express NK-associated receptors (NKRs) that may regulate their cytolytic function. We have characterized the expression of several NKRs on peripheral blood CD8+ T cells from melanoma patients and compared them to age-matched healthy
Autor:
Verónica Pérez-Guijo, Alejandro Escudero, M. J. De La Torre, J Peña, MC Muñoz-Villanueva, M Sánchez, R. J. González, R Veroz, Eduardo Collantes-Estevez, E Muñoz
Publikováno v:
Revue du Rhumatisme. 69:886-891
Resume Objectif. Evaluer les relations entre la presence des differents genes HLA-DRB1 et la predisposition a developper une spondylarthrite ankylosante (SA) sporadique dans une population bien definie. Methodes. Cent quinze patients ayant une SA spo
Autor:
Eduardo Collantes-Estevez, E Muñoz, MC Muñoz-Villanueva, R Veroz, Alejandro Escudero, M Sánchez, Verónica Pérez-Guijo, R González, J Peña
Publikováno v:
Joint Bone Spine. 69:458-462
Objective. To evaluate the relationship between the presence of different HLA-DRB1 genes and predisposition to develop a sporadic form of ankylosing spondylitis (AS) in a demographically well-defined population. Methods. One hundred fifteen selected
Autor:
G. Solórzano, Juan A. Vallejo, Javier Padillo, Jordi Muntané, Pilar Rioja, Ruben Ciria, Manuel de la Mata, MC Muñoz-Villanueva, Antonio Sitges-Serra
Publikováno v:
European journal of gastroenterologyhepatology. 22(11)
Backgrounds Patients with liver cirrhosis suffer various degrees of cardiac dysfunction which may be crucial in determining the outcome of surgery. The aim of this study was to determine the role of natriuretic peptides on the assessment of cardiac d
Autor:
J. Gratacos-Masmitja, J D Cañete-Crespillo, MC Muñoz-Villanueva, P. Zarco-Montejo, C González-Fernández, Juan Carlos Torre-Alonso, R Sanmartí-Sala, Eduardo Collantes-Estevez
Some patients (20–30%) with spondyloarthropathies (SpA) have a persistent and disabling disease,1 for which a limited number of alternative therapeutic approaches exist.2 The successful results from randomised, double blind, placebo controlled tria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05971cef890c002b11de7d5e685f8d42
https://europepmc.org/articles/PMC1754394/
https://europepmc.org/articles/PMC1754394/
Autor:
Alejandro Escudero, E Muñoz-Gomariz, C Castro, J Gonzalez, M Romero, José Peña, FG Martinez, Rafael Solana, Maria Angeles Aguirre, Verónica Pérez-Guijo, MC Muñoz-Villanueva, Eduardo Collantes
Publikováno v:
Speaker abstracts 2001.
Background To evaluate the relationship between the presence of HLA-DRB1 genes and predisposition to AS in a demographically well-defined population. Objectives 113 individuals with sporadic (non-familial) Ankylosing Spondylitis (AS) from six differe